By John Stang
Nonproliferation advocates and medical isotopes companies hope to persuade the U.S. Nuclear Regulatory Commission that a Belgian company should not receive additional highly enriched uranium from the United States to make its own isotopes.
The regulator…
Nuclear Security & Deterrence Monitor Vol. 23 No. 38
Visit Archives | Return to Issue PDF
Visit Archives | Return to Issue PDF
Nuclear Security & Deterrence Monitor
Article 10 of 13
October 04, 2019
Isotope Companies, Nonproliferation Advocates Oppose New HEU Export License
Partner Content
Jobs